NEXT EVENT!
Silicon Dragon
Hong Kong 2019
Early bird rate
ends April 10
VC Dealmakers
Yuan Liu
, ZhenFund
Ming Yeh, CSC UpShot
Duncan Chiu,
Radiant VC
Chibo Tang
HK Alibaba Entrepreneurs Fund
Will Cai
, Cooley Ryan Reynoldson, KPMG
Investor/Founder Chats
Pitches
|
Silicon Dragon
Beijing 2019
April 25
featuring
Martin Suter, head of China digital commerce with team,
Anheuser-Busch
He Xiaopeng, founder, Xpeng Motors
VC Dealmakers
Jixun Foo, GGV Capital David Yuan,
Redpoint China
William Bao Bean,
Chinaccelerator/MOX
Hurst Lin, DCM
Henry Yin
, Cooley
Program, Reception,
VIP Dinner
|
SAVE THE DATE
Silicon Dragon LA
2019
|
on Amazon
VIDEO
|
Tech Titans of China - Author interview |
|
VIP Invitations
Special Event Discounts
Introductions
FOLLOW US
@RFannin
@SiliconDragon
|
|
|
Does It Have To Be US Vs. Them (China)?
As China doubles down on its goal to achieve supremacy with national high-tech champions that can compete globally, separate spheres of power are forming: China in Asia and the US in the West.
China's tech giants are getting ahead quickly in the fast-growing Asian region ─ proximity and consumer familiarity with Chinese brands and digitally advanced features helps. Meanwhile, several American technology leaders continue to be blocked from China, and have not been as aggressive as the Chinese in entering Southeast Asia. The tech universe of the future will be regional innovation powerhouses moving in parallel with neither dominating worldwide.
Today, I am hearing the issue of growing US-China competition discussed more often among business leaders, policy makers and venture investors. At the recent China Insitute conference,
David Chen of
AngelVest questioned why there is so much talk about "us versus them." Chen and others who practice in this cross-border investment alley wonder why it can't be more "us."
The result of this mutual distrust already is leading to different tech worlds vying for leadership. This trend, as it evolves, could hamper tech innovation globally, hardly a favorable outcome, points out
Gary Rieschel of
Qiming Venture Partners.
Read more about this topic in my new book,
China Scores High in World's Top 100 VC Rankings
China scored high in the annual
Forbes
ranking of top high-tech venture capitalists. Massive venture capital fund raisings by Chinese companies Meituan-Dianping, DiDi Chuxing, and JD.com helped launch investors from Capital Today, GGV Capital, and DST Global to the List. Meanwhile, investors from Gaorong Capital, BlueRun Ventures, Qiming Venture Partners, and ZhenFund arrived following their investments in other Chinese companies across a range of technology subsectors. Besides Neil Shen of Sequoia Capital China, ranked first, other high scorers were
James Mi
of
Lightspeed China
, #12 on the list, a backer of Chinese hotshot companies
Pinduoduo
and
Meituan,
which
both listed in 2018.
China newcomers to the list include Kathy Xu of Capital Today, (#6), Zhen Zhang (#20) and Xiang Gao (#30) of Gaorong Capital, John Lindfors (#41) of DST Global, Jui Tan (#48) of BlueRun Ventures, Nisa Leung (#54) of Qiming Venture, and Anna Fang Hamm (#89) of ZhenFund.
Read more,
Counting to 100, at
Forbes. China breaks through on the top 100 VCs list globally.
VENTURE DEALS
China's GoPro rival
Insta360 raises $30 million from investors
Everest Venture Capital, MG Holdings and
Huajin Capital as it looks toward an IPO in 2020.
Indonesia's Kargo comes out of stealth with $7.6 million from Travis Kalanick, Sequoia, ZhenFund and others.
If Cred India raises this $100 million from Hillhouse Capital and existing investors, it could join the fast-growing unicorn list.
Qiming Venture Partners leads $42 million B round in Chinese biotech startup Abbisko Therapeutics.
Lightspeed China has co-led a $80 million, Series C round in Chinese SaaS startup IfChange, an online HR platform in Shanghai.
FUNDS
A $50 million blockchain fund, Proof of Capital, is launching by a trio of VCs:
Phil Chen
, previously with
Horizons Ventures
,
Chris McCann
who was with
Greylock Partners
, and
Edith
Yeung, an
advisor to
500 Startups
.
More details coming.
IPOs
Eight months after filing for IPO, the maker of China's Ebola vaccine joins HKEX with a $161 million raise. The company, Tianjin-based CanSino, is the first pre-revenue vaccine maker on board at HKEX, post reforms at the exchange to bring in more biotech startups.
NOTEWORTHY
Trump's encouraging personnel pick on tech policy.
Michael Kratsios, now being elevated to the long-vacant post of US chief technology officer, is no Luddite,
by all accounts.
Forbes VC 100 listee, speaks
about "intersumer" -- a term he coined combining 'internet' and 'consumer.'
VIEWPOINT
Can China's tech industry up its game and take the lead when it comes to innovation and research?
"From next year, we expect to see big enterprise companies rising in China," said Herry Han, founding partner of Lightspeed China in SCMP.
ARCHIVE: Silicon Dragon News
Which Market Will Own The Car of the Future?
|
|
|
|